Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center

Throughout their oncologic history, approximately 80% of patients with head and neck (H&N) cancer undergo radiation therapy [1]. However, 50% of treated patients develop recurrent/secondary cancer. Thus, the H&N cancer-related death rate is approximately 60%; and over 40% of these result from locoregional progression [2].

Source: Radiotherapy and Oncology - November 23, 2023 Category: Radiology Authors: Chlo é Delerue, David Pasquier, Emilie Bogart, Xavier Mirabel, Julien Laffarguette, Séverine Lals, Maël Barthoulot, Eric Lartigau, Xavier Liem Tags: Original Article Source Type: research